Physician profile
Robert A Schwartz
NPI 1982605747
$4,029.56
in general payments reported to CMS, 2019-2025
15 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2021: $458 · 2022: $486 · 2023: $1,882 · 2024: $510 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712 · Travel and Lodging: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.39 |
| Travel and Lodging | $991.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,002.63 | 2022-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Medtronic, INC. | $603.35 | 2021-2025 | Endurant Iis |
| Endologix LLC | $294.88 | 2019 | |
| Silk Road Medical, INC. | $195.77 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Inari Medical, INC. | $162.71 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bolton Medical INC | $148.01 | 2023 | Treo Abdominal Stent-Graft System |
| Shockwave Medical, INC | $146.96 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $123.33 | 2022 | |
| Lemaitre Vascular, INC. | $119.91 | 2021-2025 | Artegraft Vascular Graft |
| Bard Peripheral Vascular, INC. | $116.30 | 2019-2021 | |
| Haemonetics Corporation | $33.31 | 2024 | Teg6s Hemostasis System |
| Neuros Medical, INC. | $26.15 | 2025 | Altius |
| Pfizer INC. | $20.79 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $20.11 | 2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $15.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.